晶泰科技
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway 2026-05-04 08:19
XtalPi Holdings Announces Full Year 2025 Annual Results 2026-03-25 22:27
XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026 2026-03-13 20:01
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development 2025-11-05 18:00
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals 2025-09-09 20:42
XtalPi Holdings Announces 2025 Interim Results 2025-08-27 22:26
XtalPi Holdings Announces 2025 Interim Results 2025-08-27 22:23
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies 2025-08-20 08:00
XtalPi Holdings Limited to Announce 2025 Interim Results on August 27, 2025 2025-08-18 18:59
XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration 2025-08-07 08:05
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations 2025-06-30 09:29
XtalPi Announces Strategic Collaboration with Harvard Professor Gregory Verdine's DoveTree LLC to Advance Novel Therapeutics Using AI+Robotics Drug Discovery Platform 2025-06-23 09:11
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration 2025-06-13 15:00
XtalPi and Kula Bio Forge Multi-Million USD Collaborative R&D Agreement to Advance AI-Driven Microbial Fertilizers in China and the Middle East 2025-03-28 21:31
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform 2025-01-09 16:41
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific 2024-11-07 11:34
Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform 2024-10-12 16:57
XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP 2024-09-24 21:00
XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024 2024-03-28 09:05
XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery 2024-01-30 21:00
1 2